These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23921255)

  • 1. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease.
    Hara M; Ando M; Morito T; Nokiba H; Iwasa Y; Tsuchiya K; Nitta K
    Nephron Clin Pract; 2013; 123(3-4):202-8. PubMed ID: 23921255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
    Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
    Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A; Viswanath V; Singh YP; Aggarwal A
    J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A12 expression in patients with primary biliary cirrhosis.
    Ma D; Li X; Zhang L; Deng C; Zhang T; Wang L; Hu C; Li Y; Zhang F
    Immunol Invest; 2015; 44(1):13-22. PubMed ID: 25313445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis.
    Achouiti A; Föll D; Vogl T; van Till JW; Laterre PF; Dugernier T; Wittebole X; Boermeester MA; Roth J; van der Poll T; van Zoelen MA
    Shock; 2013 Sep; 40(3):188-94. PubMed ID: 23846410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.
    Wittkowski H; Sturrock A; van Zoelen MA; Viemann D; van der Poll T; Hoidal JR; Roth J; Foell D
    Crit Care Med; 2007 May; 35(5):1369-75. PubMed ID: 17414728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis.
    Mori Y; Kosaki A; Kishimoto N; Kimura T; Iida K; Fukui M; Nakajima F; Nagahara M; Urakami M; Iwasaka T; Matsubara H
    Am J Nephrol; 2009; 29(1):18-24. PubMed ID: 18663285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease.
    Uchiyama-Tanaka Y; Mori Y; Kosaki A; Kimura T; Moriishi M; Kawanishi H; Matsubara H
    Ther Apher Dial; 2008 Feb; 12(1):28-32. PubMed ID: 18257809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of S100A12 in the pathogenesis of osteoarthritis.
    Nakashima M; Sakai T; Hiraiwa H; Hamada T; Omachi T; Ono Y; Inukai N; Ishizuka S; Matsukawa T; Oda T; Takamatsu A; Yamashita S; Ishiguro N
    Biochem Biophys Res Commun; 2012 Jun; 422(3):508-14. PubMed ID: 22609404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.
    Shiotsu Y; Mori Y; Nishimura M; Sakoda C; Tokoro T; Hatta T; Maki N; Iida K; Iwamoto N; Ono T; Matsuoka E; Kishimoto N; Tamagaki K; Matsubara H; Kosaki A
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):718-23. PubMed ID: 21258041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.
    Hoppmann S; Steinbach J; Pietzsch J
    Int J Biochem Cell Biol; 2010 May; 42(5):651-61. PubMed ID: 20025991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes.
    Kosaki A; Hasegawa T; Kimura T; Iida K; Hitomi J; Matsubara H; Mori Y; Okigaki M; Toyoda N; Masaki H; Inoue-Shibata M; Nishikawa M; Iwasaka T
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5423-8. PubMed ID: 15531492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.